| NCT ID | NCT01499394 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Caris Science, Inc. |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2010-11 |
| Primary Completion | 2030-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2010-11 with a primary completion date of 2030-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Capacity to provide informed consent Exclusion Criteria: * Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoners-patients will not be approached for participation in the Caris Biorepository. * Minor subjects will not be included in the Caris Biorepository, as it is possible biospecimens and data may be stored beyond the time limitations of assent and it may be impracticable to re-consent these subjects once they become adults. * Individuals who lack the capacity to give informed consent
Contact & Investigator
Mary Baker
✉ carisresearch@carisls.comMatthew Oberley, MD
PRINCIPAL INVESTIGATOR
Caris Life Sciences
Frequently Asked Questions
Who can join the NCT01499394 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01499394 currently recruiting?
Yes, NCT01499394 is actively recruiting participants. Contact the research team at carisresearch@carisls.com for enrollment information.
Where is the NCT01499394 trial being conducted?
This trial is being conducted at Mobile, United States, Scottsdale, United States, Jonesboro, United States, Little Rock, United States and 11 additional locations.
Who is sponsoring the NCT01499394 clinical trial?
NCT01499394 is sponsored by Caris Science, Inc.. The principal investigator is Matthew Oberley, MD at Caris Life Sciences. The trial plans to enroll 100,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.